Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Phase II Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load
Brief Summary: This is a study of the effect of raltegravir on human T-cell leukemia virus type 1 (HTLV-1) viral load in asymptomatic patients. The study will enroll 14 subjects for a period of 2 months of treatment and 1 month of followup. The study will assess the effect of raltegravir on virus load in peripheral blood lymphocytes, level of virus gene expression, and sites of viral integration.